Truncated AUC for long half-life drugs [Design Issues]

posted by Dr Andrew Leary – Ireland, 2009-07-01 18:57 (6199 d 04:46 ago) – Posting: # 3920
Views: 4,057

Helmut et al - Greetings from Ireland where it is pissing rain as usual (and also very green)!

The latest draft guidelines seem to suggest that it should no longer be necessary to measure out beyond 72 hours in BE studies where the drug has a long half-life (though I note that "long half-life" is not defined). Do you know whether or not practice has changed yet, or are drug companies and CROs still sampling out beyond 72 hours "just to be safe"? :-P

Kind regards

Andrew Leary

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
133 visitors (0 registered, 133 guests [including 17 identified bots]).
Forum time: 23:43 CEST (Europe/Vienna)

Science is simply common sense at its best that is,
rigidly accurate in observation, and
merciless to fallacy in logic.    Thomas Henry Huxley

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5